MedTrace Logo

Inflammatory Cytokines in Symptom Production in Multiple Myeloma

NCT00688168 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 491

Last updated 2019-05-29

No results posted yet for this study

Summary

The goal of this research study is to learn about the pain and/or other symptoms that patients may experience either while you are being monitored by your doctor before a decision is made to start you on treatment for your MM, or during and after treatment for MM, and how these symptoms may affect therapy. A second goal is to learn how differences in genes may affect the symptom burden from cancer and cancer therapy.

Conditions

Interventions

BEHAVIORAL

Questionnaire

Questionnaires measuring pain and other symptoms, mood, and quality of life.

BEHAVIORAL

Neurocognitive Testing

A neurocognitive exam (tests to check your memory and thinking abilities, for example) will be performed.

BEHAVIORAL

Neurosensory Testing

Neurosensory testing will be performed to find out how sensitive you are to things such as touch, coolness, warmth, pinprick on the finger, and squeezing of the skin on the finger, hand, or arm.

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Xin Shelley Wang, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-09
Primary Completion
2019-01-08
Completion
2019-01-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00688168 on ClinicalTrials.gov